EP3823602A4 - Inhalationszusammensetzungen mit antibakteriellen mitteln - Google Patents

Inhalationszusammensetzungen mit antibakteriellen mitteln Download PDF

Info

Publication number
EP3823602A4
EP3823602A4 EP19860985.1A EP19860985A EP3823602A4 EP 3823602 A4 EP3823602 A4 EP 3823602A4 EP 19860985 A EP19860985 A EP 19860985A EP 3823602 A4 EP3823602 A4 EP 3823602A4
Authority
EP
European Patent Office
Prior art keywords
bacterial agents
inhalation compositions
inhalation
compositions
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19860985.1A
Other languages
English (en)
French (fr)
Other versions
EP3823602A2 (de
Inventor
Ali Turkyilmaz
Irem Yenice
Devrim Celik
Arzu CAYIR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arven Ilac Sanayi ve Ticaret AS
Original Assignee
Arven Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi ve Ticaret AS filed Critical Arven Ilac Sanayi ve Ticaret AS
Publication of EP3823602A2 publication Critical patent/EP3823602A2/de
Publication of EP3823602A4 publication Critical patent/EP3823602A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
EP19860985.1A 2018-07-20 2019-07-11 Inhalationszusammensetzungen mit antibakteriellen mitteln Pending EP3823602A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201810404 2018-07-20
PCT/TR2019/050564 WO2020055356A2 (en) 2018-07-20 2019-07-11 Inhalation compositions comprising anti-bacterial agents

Publications (2)

Publication Number Publication Date
EP3823602A2 EP3823602A2 (de) 2021-05-26
EP3823602A4 true EP3823602A4 (de) 2022-04-27

Family

ID=69776573

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860985.1A Pending EP3823602A4 (de) 2018-07-20 2019-07-11 Inhalationszusammensetzungen mit antibakteriellen mitteln

Country Status (2)

Country Link
EP (1) EP3823602A4 (de)
WO (1) WO2020055356A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155806A (zh) * 2005-04-06 2008-04-02 法玛西雅厄普约翰有限责任公司 作为抗菌剂的羟吲哚唑烷酮
WO2012030645A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US20120065170A1 (en) * 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009029192A1 (en) * 2007-08-24 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Surfactant-based antimicrobial solution for inhalation
TR201105367A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
WO2013109210A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising budesonide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155806A (zh) * 2005-04-06 2008-04-02 法玛西雅厄普约翰有限责任公司 作为抗菌剂的羟吲哚唑烷酮
WO2012030645A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US20120065170A1 (en) * 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Particulate Interactions in Dry Powder Formulation for Inhalation", 1 January 2000, CRC PRESS, article ANONYMOUS: "Particulate Interactions in Dry Powder Formulation for Inhalation", pages: 158 - 159, XP055897858 *

Also Published As

Publication number Publication date
WO2020055356A2 (en) 2020-03-19
EP3823602A2 (de) 2021-05-26
WO2020055356A3 (en) 2020-05-14

Similar Documents

Publication Publication Date Title
GB201716986D0 (en) Antimicrobial compositions
EP3758495A4 (de) Nanopartikelzusammensetzungen
EP3886879A4 (de) Thrombozyten als freisetzungsmittel
EP3887402A4 (de) Thrombozyten als freisetzungsmittel
EP3443078A4 (de) Antimikrobielle zusammensetzungen
EP3740553A4 (de) Antimikrobielle konservierungsmittelzusammensetzungen
PL3444326T3 (pl) Przeciwdrobnoustrojowa kompozycja czyszcząca
EP3801020A4 (de) Herbizidzusammensetzungen
IL289548A (en) Antimicrobial preparation
EP3793359A4 (de) Eine antimikrobielle zusammensetzung
EP3758490A4 (de) Nanopartikelzusammensetzungen
EP3672944A4 (de) Reinigungszusammensetzungen
EP3801032A4 (de) Herbizidzusammensetzungen
EP3817750A4 (de) Cannabidiolkombintionszusammensetzungen
EP3829578A4 (de) Sirolimushaltige zusammensetzungen
EP3774680A4 (de) Reinigungszusammensetzungen
EP3610727A4 (de) Biozidzusammensetzung
EP3452570A4 (de) Reinigungszusammensetzungen
GB201918552D0 (en) Antimicrobial compositions
GB2594907B (en) Composition comprising anti-acanthamoeba agents
EP3874951A4 (de) Herbizidzusammensetzung
EP3703648A4 (de) Antimikrobielle zusammensetzungen
EP3823602A4 (de) Inhalationszusammensetzungen mit antibakteriellen mitteln
AU2019902768A0 (en) Anti-bacterial agent
AU2018902796A0 (en) Anti-Bacterial Agent

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210209

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220324

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/26 20060101ALI20220319BHEP

Ipc: A61P 1/00 20060101ALI20220319BHEP

Ipc: A61K 9/00 20060101ALI20220319BHEP

Ipc: A61K 31/5377 20060101ALI20220319BHEP

Ipc: A61K 9/72 20060101AFI20220319BHEP